Clinical Research Directory
Browse clinical research sites, groups, and studies.
Improve Cancer-related Cognitive Impairment
Sponsor: University of Alabama at Birmingham
Summary
Cancer-related cognitive impairment (CRCI), also known as "chemobrain," is the cognitive decline that negatively impacts the majority of cancer patients undergoing chemotherapy, radiation, and/or hormonal treatments. This application focuses on evaluating if using a cognitive mobile training application can decrease the impact of CRCI in gynecologic oncology patients through a multidisciplinary approach with patients undergoing assessments by our neurocognitive team.
Official title: Using a Novel Mobile Cognitive Training Application to Improve Cancer-related Cognitive Impairment in Gynecologic Oncology Patients
Key Details
Gender
FEMALE
Age Range
18 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
64
Start Date
2024-09-01
Completion Date
2027-08-01
Last Updated
2025-11-24
Healthy Volunteers
Yes
Interventions
Cognitive training application
Patients will participate with a cognitive training application and undergo neurocognitive testing during and after chemotherapy.
Locations (1)
University of Alabama at Birmingham
Birmingham, Alabama, United States